122 related articles for article (PubMed ID: 12738387)
21. Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination.
Jeremy AH; Du Y; Dixon MF; Robinson PA; Crabtree JE
Microbes Infect; 2006 Feb; 8(2):340-6. PubMed ID: 16213184
[TBL] [Abstract][Full Text] [Related]
22. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
[TBL] [Abstract][Full Text] [Related]
23. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
[TBL] [Abstract][Full Text] [Related]
24. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S
Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589
[TBL] [Abstract][Full Text] [Related]
25. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.
Goto T; Nishizono A; Fujioka T; Ikewaki J; Mifune K; Nasu M
Infect Immun; 1999 May; 67(5):2531-9. PubMed ID: 10225917
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
[TBL] [Abstract][Full Text] [Related]
27. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.
Sawai N; Kita M; Kodama T; Tanahashi T; Yamaoka Y; Tagawa Y; Iwakura Y; Imanishi J
Infect Immun; 1999 Jan; 67(1):279-85. PubMed ID: 9864227
[TBL] [Abstract][Full Text] [Related]
28. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization.
Czinn SJ; Cai A; Nedrud JG
Vaccine; 1993; 11(6):637-42. PubMed ID: 8322486
[TBL] [Abstract][Full Text] [Related]
29. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
30. Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
Jiang W; Baker HJ; Smith BF
Infect Immun; 2003 Jan; 71(1):40-6. PubMed ID: 12496147
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies.
Sutton P; Wilson J; Kosaka T; Wolowczuk I; Lee A
Immunol Cell Biol; 2000 Feb; 78(1):28-30. PubMed ID: 10651926
[TBL] [Abstract][Full Text] [Related]
33. Vaccination against Helicobacter pylori.
Corthésy-Theulaz I
Recent Results Cancer Res; 2000; 156():55-9. PubMed ID: 10802863
[TBL] [Abstract][Full Text] [Related]
34. Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine.
O'Riordan AA; Morales VA; Mulligan L; Faheem N; Windle HJ; Kelleher DP
Vaccine; 2012 Jun; 30(26):3876-84. PubMed ID: 22512976
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
36. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
[TBL] [Abstract][Full Text] [Related]
37. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
38. Experimental model of Helicobacter pylori infection.
Del Giudice G; Ghiara P; Rappuoli R
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S261-3. PubMed ID: 10077750
[TBL] [Abstract][Full Text] [Related]
39. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions.
Pappo J; Torrey D; Castriotta L; Savinainen A; Kabok Z; Ibraghimov A
Infect Immun; 1999 Jan; 67(1):337-41. PubMed ID: 9864234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
